Ally Bridge Group (NY) LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Ally Bridge Group (NY) LLC disclosed 29 US equity positions worth $186.8m in its Q3 2024 13F filing. The largest position was INSM at 5.9% of the reported book, followed by TARS and MERUS N V.
What did Ally Bridge Group (NY) LLC own in Q3 2024? Top 29 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 5.9% | $11.0m | 150,833 | – | |
| 2 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 5.7% | $10.6m | 321,898 | – | |
| 3 | MERUS N V | 5.6% | $10.4m | 208,244 | – | ||
| 4 | CGON CG ONCOLOGY INC | Healthcare | 5.3% | $9.9m | 263,266 | – | |
| 5 | 2655787D BLUEPRINT MEDICINES CORP | 5.3% | $9.8m | 106,080 | – | ||
| 6 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 4.8% | $9.0m | 72,000 | – | |
| 7 | XENE XENON PHARMACEUTICALS INC | Healthcare | 4.5% | $8.3m | 211,791 | – | |
| 8 | LONGBOARD PHARMACEUTICALS IN | 4.3% | $8.0m | 240,892 | – | ||
| 9 | JSPR JASPER THERAPEUTICS INC | 4.0% | $7.5m | 399,466 | – | ||
| 10 | RVMD REVOLUTION MEDICINES INC | Healthcare | 4.0% | $7.4m | 163,500 | – | |
| 11 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 3.9% | $7.3m | 227,700 | – | ||
| 12 | TYRA TYRA BIOSCIENCES INC | Healthcare | 3.4% | $6.3m | 270,075 | – | |
| 13 | CLYM ELIEM THERAPEUTICS INC | 3.3% | $6.3m | 1,229,292 | – | ||
| 14 | GERN GERON CORP | Healthcare | 3.2% | $6.0m | 1,331,053 | – | |
| 15 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 3.2% | $6.0m | 234,856 | – | |
| 16 | KURA KURA ONCOLOGY INC | Healthcare | 3.1% | $5.7m | 294,081 | – | |
| 17 | APLT APPLIED THERAPEUTICS INC | 2.8% | $5.3m | 618,332 | – | ||
| 18 | EWTX EDGEWISE THERAPEUTICS INC | 2.7% | $5.0m | 187,695 | – | ||
| 19 | CNTA CENTESSA PHARMACEUTICALS | 2.7% | $5.0m | 309,614 | – | ||
| 20 | JANX JANUX THERAPEUTICS INC | Healthcare | 2.6% | $4.9m | 108,811 | – | |
| 21 | IRON DISC MEDICINE INC | Healthcare | 2.6% | $4.9m | 100,000 | – | |
| 22 | CATX PERSPECTIVE THERAPEUTICS INC | 2.4% | $4.6m | 341,739 | – | ||
| 23 | BRD1EUR MIND MEDICINE MINDMED INC | 2.4% | $4.5m | 788,508 | – | ||
| 24 | ALMS ALUMIS INC | 2.4% | $4.5m | 418,416 | – | ||
| 25 | RLAY RELAY THERAPEUTICS INC | Healthcare | 2.4% | $4.4m | 626,058 | – | |
| 26 | TRVI TREVI THERAPEUTICS INC | Healthcare | 2.4% | $4.4m | 1,322,800 | – | |
| 27 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 2.3% | $4.2m | 73,185 | – | |
| 28 | CNTX CONTEXT THERAPEUTICS INC | 1.8% | $3.4m | 1,757,524 | – | ||
| 29 | PROMIS NEUROSCIENCES INC | 1.1% | $2.0m | 1,592,605 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.